Viral lode amounts while on pegintron and ribivirn
Dec 9, 2006
Viral lode was 1,040,000 when starting pegintron/ribivirn. Normal liver function, no disease as yet, genotype one.
After 5 weeks(of planned 48 weeks) on treatment, viral lode was 37,000. After 11 weeks it is 1650. We had hoped it would be zero after the HUGE drop in the first 5 weeks.Does this mean there is a chance the virus will not clear? Or, is this normal numbers at this point? If it is not to zero at a later point, does this mean it won't work?????? THANKS SO MUCH.
Response from Dr. Holodniy
You have had almost a 3 log drop in 11 weeks. Successful treatment response is predicted by at least a 2 log drop in HCV viral load by 12 weeks, so by most accounts you are ahead of the game. More recent data has suggested that an undetectable viral load at this point is predictive of a sustained viral response (SVR, which is an undetectable HCV viral load measured 6-12 months after successfully completing treatment). There is certainly a chance that you won't clear the virus, but things look good at this point.
Get Email Notifications When This Forum Updates or Subscribe With RSS
- How Much Blood Is Needed To Contract Hiv?
- If You Have Sex With Someone Hiv Postive What Are The Chances Of You Becoming Infected?
- Can A Blood Test To Check Your Iron Detect Hiv?
- Negative Hiv And Thrush
- What Does It Mean When A Hepatitis C Test Is Non-reactive?
- What Part Of The Immune System Does Hiv Attack?
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.